Thiodiglycolic acid as a possible causative agent of fixed drug eruption provoked only after continuous administration of S-carboxymethyl-L-cysteine: Case report and review of reported cases [15]

British Journal of Dermatology

Volumn 153, Issue 1, 2005, Pages 226-228

  Adachi, A ^a   Sarayama, Y ^a   Shimizu, H ^a   Yamada, Y ^b   Horikawa, T ^b  

^a Hyogo Prefectural Kakogawa Hospital   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOCISTEINE; DRUG METABOLITE; GLYCOLIC ACID DERIVATIVE; THIODIACETIC ACID; UNCLASSIFIED DRUG;

ADULT; CASE REPORT; DRUG ERUPTION; DRUG HYPERSENSITIVITY; ERYTHEMA; FEMALE; HUMAN; LETTER; PATCH TEST; PRIORITY JOURNAL; PROVOCATION TEST; SCHOOL CHILD;

ADULT; AGED; CARBOCYSTEINE; CHILD; DRUG ADMINISTRATION SCHEDULE; DRUG ERUPTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; THIOGLYCOLATES;

EID: 22944467521     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06712.x     Document Type: Letter

References (9)

1. Korkij W, Soltani K. Fixed drug eruption - a brief review. Arch Dermatol 1984; 120:520-4.
2. Kaupinen K, Stubb S. Fixed eruptions - causative drugs and challenge tests. Br J Dermatol 1985; 112:575-8.
3. Kawaguchi T, Yamamoto M. A case of fixed drug eruption due to carbocysteine that took two days to be provoked. Jpn J Dermatoallergol 2000; 8:125-8 (in Japanese).
4. Harada S, Shimizu H. A case of fixed drug eruption due to continuous intake of carbocysteine. Jpn J Dermatoallergol 2003; 11:57-61 (in Japanese).
5. Hamanaka H, Mizutani H, Nouchi N et al. Allopurinol hypersensitivity syndrome: hypersensitivity 10 oxypurinol but not allopurinol. Clin Exp Dermatol 1998; 23:32-4.
6. Steventon GB. Diurnal variation in the metabolism of S-carboxymethyl-L- cysteine in humans. Drug Metab Dispos 1999; 27:1092-7.
7. Ohtani T, Hiroi A, Sakurane M, Furukawa F. Slow acetylator genotypes as a possible risk factor for infectious mononucleosis-like syndrome induced by salazosulfapyridine. Br J Dermatol 2003; 148:1035-9.
8. Michell SC, Warning RH. The deficiency of sulfoxidation of S-carboxymethyl-L-cysteine. Pharmac Ther 1989; 43:237-49.
9. Michell SC, Warning RH, Haley CS et al. Genetic aspects of polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man. Br J Clin Pharmac 1984; 18:507-52.